Table 3. Mean (± SEM) Age and Clinical Status of Children With Sickle Cell Disease as a Function of Plasma Retinol Concentration
VariablePlasma Retinol <20 μg/dL (n = 7)aPlasma Retinol ≥20 μg/dL (n = 52)aP ValuePlasma Retinol <20 μg/dL (n = 5 boys with HbSS)Plasma Retinol ≥20 μg/dL (n = 18 boys with HbSS)P Value
Age, years8.81 ± 1.17.47 ± 0.658.87 ± 1.517.22 ± 0.80
Weight, kg26.83 ± 2.8225.54 ± 2.3325.38 ± 3.3522.53 ± 2.25
Weight percentile28.21 ± 10.7737.72 ± 4.6220.50 ± 9.2523.06 ± 5.89
Height, cm131.5 ± 6.22119.26 ± 4.45128.8 ± 7.52118.64 ± 6.99
Height percentile22.5 ± 5.8240.28 ± 4.870.0925.07 ± 6.6126.31 ± 7.46
Pain crises1.57 ± 0.430.72 ± 0.190.051.40 ± 0.510.82 ± 0.23
Units of blood0.71 ± 0.711.17 ± 0.331.00 ± 0.9981.35 ± 0.64
Infections0.57 ± 0.2970.58 ± 0.130.60 ± 0.3990.81 ± 0.28
Hospitalizations1.86 ± 0.961.43 ± 0.271.20 ± 0.5822.07 ± 0.59
Hematocrit, %26.5 ± 1.8727.78 ± 0.6925.10 ± 2.2824.22 ± 0.78
Hemoglobin, g/dL8.50 ± 0.548.79 ± 0.28.22 ± 0.647.74 ± 0.18
White blood cells × 106/mL12.10 ± 0.9712.69 ± 0.7511.57 ± 1.1114.57 ± 1.26
C-reactive protein, mg/L18.27 ± 12.85.50 ± 1.640.0525.58 ± 17.238.38 ± 4.240.08
Alpha-1-acid glycoprotein, g/L071 ± 0.190.69 ± 0.040.83 ± 0.220.66 ± 0.08
Retinol binding protein, mg/L19.30 ± 4.0621.56 ± 1.1414.72 ± 2.7619.22 ± 1.81
Tumor necrosis factor-α, pg/mL32.71 ± 19.750.61 ± 13.6433.74 ± 28.0569.73 ± 28.62
Inflammation score0.71 ± 0.290.35 ± 0.080.070.80 ± 0.370.33 ± 0.160.1
Health scoreb5.43 ± 1.673.84 ± 0.615.20 ± 1.834.83 ± 1.09
  • a All hemoglobin phenotypes included.

  • b Health score is the sum of the number of episodes of pain crisis, infection, hospital admission, and/or blood units received.